Trevigen Releases CultreCoat® Cell Adhesion Assays
A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may significantly impact cell activities. What is desired then is an assay system providing a variety of ECM proteins in a quantitative, high throughput format.
Trevigen answers this need with a simple, standardized, high throughput adhesion assay format offering 96 well plates coated with Basement Membrane Extract, Laminin I, Collagen I, Collagen IV, Fibronectin, Vitronectin, or an array of all six ECM proteins. A black stripwell format minimizes background providing increased sensitivity. Calcein labeling allows direct comparison between the number of cells loaded and the number of cells that adhere, and additional controls are provided for determining background and non-specific binding.
Highly qualified ECM proteins are also available separately from Trevigen.
Trevigen, Inc. focuses on the development, manufacturing and marketing of technology and products for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell behavior.
Press Contact: Shamain Dang
8405 Helgerman Court
Gaitherburg, MD 20877
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trevigen Releases CultreCoat® Cell Adhesion Assays here
News-ID: 69494 • Views: 2129
More Releases from Trevigen, Inc.
HT PARP in vivo Pharmacodynamic Assay II
Trevigen announces a validated assay, with higher sensitivity and pre-coated antibody plates to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening. Pharmacodynamic (PD) assays have recently been developed and employed early in the drug screening process to assess the ability of potential drug candidates to affect molecular targets. These assays have the advantages of performing molecular proof-of-concept investigations at an early stage such as
Trevigen Announces the First Standardized Comet Assay Electrophoresis System
The comet assay is the only direct method for the detection of DNA damage in cells. It is used in cancer research, in genotoxicity studies on environmental mutagens, and for screening compounds for cancer therapeutics. Based on single cell gel electrophoresis in a controlled pH environment, the assay allows the integrity of stained nuclear DNA to be examined and measured. Until now, a lack of standardization in electrophoresis equipment, control cells,
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Ass …
Poly(ADP-ribose) polymerase, through ribosylation of nuclear proteins, converts DNA Damage into intracellular signals that actuate either DNA repair or cell death. The development of inhibitors to PARP is of ever increasing interest in the drug discovery community since they can be used as modulators of DNA repair mediated resistance to cytotoxic cancer therapeutics. Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these
Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to “3-D” Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play
More Releases for Assay
Stem Cell Assay Market Drivers And Outlook
North America and Europe are expected to witness significant growth in the market over the forecast period. This is owing to presence of key manufacturers and researchers of stem cell based therapies in these regions. Moreover, manufacturers such as ThermoFisher Scientific, and Agilent Technologies, Inc. providing stem cell assay are present in North America region, which fuel growth of the market. Asia Pacific region is expected to show significant growth
Protein Assay Market : Global Snapshot by 2025
The protein assay market is anticipated to witness strong growth during the forecast period owing to growing pharmaceutical & biotechnology R&D and increase emphasis on proteomics research. The global protein assay market can be segmented based on type, product, technology, application, end user, and region. On the basis of type, the protein assays market can be segmented into dye binding protein assays (Bradford), copper ions based protein assays (Lowry), test
High Throughput Flow Assay Trends 2017
ReportsWorldwide has announced the addition of a new report High Throughput Flow Assay Trends 2017 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on high throughput flow cytometry (HT flow) screening carried out in January 2017. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update HTStec's previous HT
Biomarker Assay Market Supply Demand 2016-2020
Biomarkers are defined as measurable indicators of a particular disease or condition that are evaluated to diagnose and confirm the presence or absence of regular biological processes, pathogens and efficacy of pharmacological intervention. Biomarkers can be chemicals and compounds that are freely available in the body and are present in greater or lower concentrations as compared with control (normal) state. The concept is used on various disease areas within healthcare
ELISA Assay Dispensing Trends 2016
ReportsWorldwide has announced the addition of a new report ELISA Assay Dispensing Trends 2016 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on enzyme-linked immunosorbent assays (ELISA) carried out in April 2016. The survey was initiated by HTStec as part of its tracking of life science marketplaces and to update HTStec's previous ELISA Assay Trends report (June 2012).
The Comet Assay: Nutrition & Health
Last year we highlighted research linking nutritional factors, mutagenicity and carcinogenesis. One invaluable tool for investigations into DNA damage, protection and repair is the Comet Assay (Single Cell Gel Electrophoresis). The growing popularity & acceptance of the assay is evident by the number of peer reviewed papers in the scientific literature. Here we list a selection of recent papers with nutrition & health a key theme and all using data